Patents by Inventor Julia ANZENGRUBER

Julia ANZENGRUBER has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • PURIFICATION OF FACTOR VIII SUBSPECIES
    Publication number: 20220275058
    Abstract: The present invention relates to a method for purifying a Factor VIII (FVIII) subspecies from a composition comprising FVIII, said method comprising an anion exchange chromatography step, a size exclusion chromatography step, and a concentration step. The invention also relates to a composition comprising a purified FVIII subspecies.
    Type: Application
    Filed: March 7, 2022
    Publication date: September 1, 2022
    Applicant: TAKEDA PHARMACEUTICAL COMPANY LIMITED
    Inventors: Meinhard Hasslacher, Martin Feichtinger, Philipp M. Bärnthaler, Christa Mayer, Birgit Reipert, Mantas Malisauskas, Julia Anzengruber
  • Purification of factor VIII subspecies
    Patent number: 11299533
    Abstract: The present invention relates to a method for purifying a Factor VIII (FVIII) subspecies from a composition comprising FVIII, said method comprising an anion exchange chromatography step, a size exclusion chromatography step, and a concentration step. The invention also relates to a composition comprising a purified FVIII subspecies.
    Type: Grant
    Filed: June 22, 2018
    Date of Patent: April 12, 2022
    Assignee: TAKEDA PHARMACEUTICAL COMPANY LIMITED
    Inventors: Meinhard Hasslacher, Martin Feichtinger, Philipp M. Bärnthaler, Christa Mayer, Birgit Reipert, Mantas Malisauskas, Julia Anzengruber
  • PURIFICATION OF FACTOR VIII SUBSPECIES
    Publication number: 20190062403
    Abstract: The present invention relates to a method for purifying a Factor VIII (FVIII) subspecies from a composition comprising FVIII, said method comprising an anion exchange chromatography step, a size exclusion chromatography step, and a concentration step. The invention also relates to a composition comprising a purified FVIII subspecies.
    Type: Application
    Filed: June 22, 2018
    Publication date: February 28, 2019
    Applicants: Baxalta Incorporated, Baxalta GmbH
    Inventors: Meinhard HASSLACHER, Martin FEICHTINGER, Philipp M. BÄRNTHALER, Christa MAYER, Birgit REIPERT, Mantas MALISAUSKAS, Julia ANZENGRUBER